Medical experts explore approaches for addressing suboptimal outcomes in systemic psoriasis treatments, including methods to enhance therapeutic efficacy and criteria for transitioning to alternative treatments.
Study Compares Dose Escalation with Biologics in Psoriasis
The Cutaneous Connection: An Inside Look of the Inclusive Atlas
Oral Zasocitinib Demonstrates Safety and Efficacy in Moderate to Severe Plaque Psoriasis
The Cutaneous Connection: Episode 31- Molecular Targeting of Psoriasis Biologics
Patients With Psoriasis Demonstrate Higher Rates of Helicobacter Pylori Infection Versus Controls
Higher Risankizumab Adherence with New Injection Device